Global Metastatic Cancer Treatment Market Analysis & Forecasts 2018-2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 11, 2018--The “Global Metastatic Cancer Treatment Market - Focus on Drugs, Competitive Landscape, and Country - Analysis and Forecast (2018-2025)” report has been added to ResearchAndMarkets.com’s offering.
The healthcare industry is a multi-billion dollars market consisting of various verticals aimed at improving patient lives. With increase in research and developmental activities, technological advancements are being made to make patient services convenient and affordable. Cancer represents one of the major concern of the global healthcare industry, as it is the second leading cause of death all around the world (according to WHO). Cancer statistics has a major impact on society across the world and accounts for almost 70% of death in low- and middle- income countries. As per GLOBOCAN data, there were almost 14 million cancer cases globally in 2012, which claimed almost 8 million patient lives. As a result, enormous scientific innovation is taking place in the field of oncology for the development of novel oncology medicines that are significantly propelling the growth of metastatic cancer treatment market. Metastatic cancer, represents the advanced form of cancer, which occurs when the cancer cells starts spreading from the primary site of origin to different parts of the body.
The metastatic cancer treatment market consists of products, such as generic medicines and branded medicines, used in the treatment of metastatic cancer. The market analysis includes an in-depth examination of the key ecosystem players, key strategies, and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges) and industry analysis.
Companies MentionedAbbVie, Inc. Amgen, Inc. AstraZeneca PLC Bayer AG Boehringer Ingelheim International GmbH BRISTOL-MYERS SQUIBB COMPANY CELGENE CORPORATION Eli-Lilly and Company F. Hoffmann-La Roche AG JOHNSON & JOHNSON Merck & Co., Inc. Novartis AG Pfizer, Inc. SANOFI Takeda Pharmaceutical Company Limited bluebird bio, Inc. Clovis Oncology, Inc. IDERA PHARMACEUTICALS, INC. eTheRNA immunotherapies NV
Key Topics Covered:
1 Market Overview
2 Market Dynamics
3 Industry Insights
4 Competitive Landscape
5 Global Metastatic Cancer Treatment Market, By Therapeutic Application
6 Global Metastatic Cancer Treatment Market, By Product
7 Global Metastatic Cancer Treatment Market, By Region
8 Company Profiles
9 Report Scope and Methodology
For more information about this report visit https://www.researchandmarkets.com/research/9jfcd3/global_metastatic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180711005349/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Oncology Drugs
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/11/2018 06:00 AM/DISC: 07/11/2018 06:01 AM